Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 59.30
-0.40 (-0.67%)
Jan 13, 2026, 10:05 AM CST
TPE:1720 Market Cap
TPE:1720 has a market cap or net worth of 10.67 billion as of January 12, 2026. Its market cap has decreased by -5.24% in one year.
Market Cap
10.67B
Enterprise Value
12.61B
Revenue
6.91B
Ranking
n/a
PE Ratio
11.95
Stock Price
59.30
Market Cap Chart
Since March 4, 1996, TPE:1720's market cap has increased from 2.29B to 10.67B, an increase of 365.04%. That is a compound annual growth rate of 5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 10.74B | 2.04% |
| Dec 31, 2025 | 10.53B | -4.85% |
| Dec 31, 2024 | 11.06B | -6.07% |
| Dec 29, 2023 | 11.78B | 7.15% |
| Dec 30, 2022 | 10.99B | 42.69% |
| Dec 30, 2021 | 7.70B | 14.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.62B |
| PharmaEssentia | 189.36B |
| Lotus Pharmaceutical | 76.92B |
| Bora Pharmaceuticals Co., LTD. | 64.12B |
| Heron Neutron Medical | 59.70B |
| Oneness Biotech | 33.15B |
| Lumosa Therapeutics | 31.67B |
| Center Laboratories | 30.53B |